- Statement by Dinesh Thakur Regarding US Government’s Case Against Ranbaxy (PDF)
- Key Facts: United States of America ex rel. Dinesh S. Thakur v. Ranbaxy et al. (PDF)
- DOJ Press Release: “Generic Drug Manufacturer Ranbaxy Pleads Guilty and Agrees to Pay $500 Million to Resolve False Claims Allegations, cGMP Violations and False Statements to the FDA“
- US District Court in Massachusetts order in US Antitrust Litigation Against Ranbaxy
Dinesh Thakur
Safe and effective generic medications
Hello Mr. Thakur,
My name is Bhargav Krishna, and I’m a doctoral student at the Harvard TH Chan School of Public Health. I’ve read Katherine Eban’s book, and about your harrowing escapades with Ranbaxy, and was wondering if you would be interested in speaking to students at the school here on challenges with quality of generics, and implications on access to medicines more broadly. I’m also head of the South Asian Students Association here, and my email is bkrishna@hsph.harvard.edu. Please do let us know if you’ll be coming to Boston at any time, and we would be delighted to host you for a discussion.
Thanks.
Hello I have got an assignment ,study on Dinesh thakur whistle blower I would like to personally meet Thakur sir and have a small motivational conversation with him .. please let me know if possible
Waiting for your reply
@eashanrao786@gmail.com
You can write to me at dinesh.thakur@gmail.com
I just finished bottle of lies. Amazing and inspiring.
Sir please draft a note/demand which we should send to our MP/MLA for better outcomes in this field.